The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.
Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
n/a | 3 | 8 | 5 |
Growth
|
n/a | 75 | 89 | 73 |
Safety
|
n/a | 31 | 42 | 98 |
Sentiment
|
n/a | 31 | 92 | 56 |
|
n/a | 10 | 77 | 72 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Analyst Opinions
|
n/a | 12 | 81 | 90 |
Opinions Change
|
n/a | 50 | 50 | 18 |
Pro Holdings
|
n/a | 56 | 78 | 8 |
Market Pulse
|
n/a | 48 | 78 | 91 |
Sentiment
|
n/a | 31 | 92 | 56 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
n/a | 3 | 8 | 5 |
Growth
|
n/a | 75 | 89 | 73 |
|
n/a | 31 | 42 | 98 |
Combined
|
n/a | 12 | 38 | 73 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Price vs. Sales (P/S)
|
n/a | 1 | 1 | 6 |
Price vs. Earnings (P/E)
|
n/a | 23 | 24 | 22 |
Price vs. Book (P/B)
|
n/a | 12 | 31 | 17 |
Dividend Yield
|
n/a | 1 | 1 | 1 |
Value
|
n/a | 3 | 8 | 5 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Revenue Growth
|
n/a | 78 | 61 | 63 |
Profit Growth
|
n/a | 1 | 96 | 44 |
Capital Growth
|
n/a | 100 | 67 | 96 |
Stock Returns
|
n/a | 79 | 57 | 53 |
Growth
|
n/a | 75 | 89 | 73 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Leverage
|
n/a | 100 | 100 | 100 |
Refinancing
|
n/a | 7 | 21 | 15 |
Liquidity
|
n/a | 21 | 18 | 96 |
|
n/a | 31 | 42 | 98 |
Discover high‑ranked alternatives to Inari Medical and broaden your portfolio horizons.
The Obermatt Advantage
Choose the Obermatt subscription that best fits your needs.